Matches in SemOpenAlex for { <https://semopenalex.org/work/W1860174057> ?p ?o ?g. }
- W1860174057 endingPage "2735" @default.
- W1860174057 startingPage "2729" @default.
- W1860174057 abstract "The short in vivo half-life of IFN-gamma can prevent the cytokine from inducing immunological changes that are favorable for the treatment of Th2-dominant diseases, such as atopic dermatitis. To examine whether a sustained supply of IFN-gamma is effective in regulating the balance of Th lymphocyte subpopulations, plasmid vector encoding mouse IFN-gamma, pCpG-Mugamma, or pCMV-Mugamma was injected into the tail vein of NC/Nga mice, a model for human atopic dermatitis. A single hydrodynamic injection of a CpG motif reduced pCpG-Mugamma at a dose of 0.14 microg/mouse resulted in a sustained concentration of IFN-gamma in the serum, and the concentration was maintained at >300 pg/ml over 80 d. The pCpG-Mugamma-mediated IFN-gamma gene transfer was associated with an increase in the serum concentration of IL-12, reduced production of IgE, and inhibition of mRNA expression of IL-4, -5, -10, -13, and -17 and thymus and activation-regulated chemokine in the spleen. These immunological changes were not clearly observed in mice receiving two injections of 20 microg pCMV-Mugamma, a CpG-replete plasmid DNA, because of the transient nature of the expression from the vector. The mice receiving pCpG-Mugamma showed a significant reduction in the severity of skin lesions and in the intensity of their scratching behavior. Furthermore, high transepidermal water loss, epidermal thickening, and infiltration of lymphocytes and eosinophils, all of which were obvious in the untreated mice, were significantly inhibited. These results indicate that an extraordinary sustained IFN-gamma expression induces favorable immunological changes, leading to a Th1-dominant state in the atopic dermatitis model." @default.
- W1860174057 created "2016-06-24" @default.
- W1860174057 creator A5004784208 @default.
- W1860174057 creator A5007792165 @default.
- W1860174057 creator A5023533946 @default.
- W1860174057 creator A5028043688 @default.
- W1860174057 creator A5031183689 @default.
- W1860174057 creator A5035791716 @default.
- W1860174057 creator A5040964436 @default.
- W1860174057 creator A5050031455 @default.
- W1860174057 creator A5055850706 @default.
- W1860174057 creator A5071041099 @default.
- W1860174057 date "2010-03-01" @default.
- W1860174057 modified "2023-10-16" @default.
- W1860174057 title "Sustained Exogenous Expression of Therapeutic Levels of IFN-γ Ameliorates Atopic Dermatitis in NC/Nga Mice via Th1 Polarization" @default.
- W1860174057 cites W1827839547 @default.
- W1860174057 cites W1963846273 @default.
- W1860174057 cites W1965918908 @default.
- W1860174057 cites W1967686432 @default.
- W1860174057 cites W1972188839 @default.
- W1860174057 cites W1974700453 @default.
- W1860174057 cites W1975231760 @default.
- W1860174057 cites W1983871703 @default.
- W1860174057 cites W1989190923 @default.
- W1860174057 cites W1991195369 @default.
- W1860174057 cites W1991307757 @default.
- W1860174057 cites W1995080846 @default.
- W1860174057 cites W1999358069 @default.
- W1860174057 cites W1999531505 @default.
- W1860174057 cites W2000105955 @default.
- W1860174057 cites W2005659566 @default.
- W1860174057 cites W2006315542 @default.
- W1860174057 cites W2015627525 @default.
- W1860174057 cites W2021693767 @default.
- W1860174057 cites W2025961918 @default.
- W1860174057 cites W2033901933 @default.
- W1860174057 cites W2037333379 @default.
- W1860174057 cites W2039627333 @default.
- W1860174057 cites W2048126532 @default.
- W1860174057 cites W2050736899 @default.
- W1860174057 cites W2058286562 @default.
- W1860174057 cites W2079084782 @default.
- W1860174057 cites W2079584322 @default.
- W1860174057 cites W2091372349 @default.
- W1860174057 cites W2093730193 @default.
- W1860174057 cites W2100321403 @default.
- W1860174057 cites W2104999336 @default.
- W1860174057 cites W2126770689 @default.
- W1860174057 cites W2131227262 @default.
- W1860174057 cites W2137722996 @default.
- W1860174057 cites W2140873245 @default.
- W1860174057 cites W2149556394 @default.
- W1860174057 cites W2151165319 @default.
- W1860174057 cites W2154376533 @default.
- W1860174057 cites W2161000167 @default.
- W1860174057 cites W2320147764 @default.
- W1860174057 doi "https://doi.org/10.4049/jimmunol.0900215" @default.
- W1860174057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20107184" @default.
- W1860174057 hasPublicationYear "2010" @default.
- W1860174057 type Work @default.
- W1860174057 sameAs 1860174057 @default.
- W1860174057 citedByCount "60" @default.
- W1860174057 countsByYear W18601740572012 @default.
- W1860174057 countsByYear W18601740572013 @default.
- W1860174057 countsByYear W18601740572014 @default.
- W1860174057 countsByYear W18601740572015 @default.
- W1860174057 countsByYear W18601740572016 @default.
- W1860174057 countsByYear W18601740572017 @default.
- W1860174057 countsByYear W18601740572018 @default.
- W1860174057 countsByYear W18601740572019 @default.
- W1860174057 countsByYear W18601740572020 @default.
- W1860174057 countsByYear W18601740572021 @default.
- W1860174057 countsByYear W18601740572022 @default.
- W1860174057 countsByYear W18601740572023 @default.
- W1860174057 crossrefType "journal-article" @default.
- W1860174057 hasAuthorship W1860174057A5004784208 @default.
- W1860174057 hasAuthorship W1860174057A5007792165 @default.
- W1860174057 hasAuthorship W1860174057A5023533946 @default.
- W1860174057 hasAuthorship W1860174057A5028043688 @default.
- W1860174057 hasAuthorship W1860174057A5031183689 @default.
- W1860174057 hasAuthorship W1860174057A5035791716 @default.
- W1860174057 hasAuthorship W1860174057A5040964436 @default.
- W1860174057 hasAuthorship W1860174057A5050031455 @default.
- W1860174057 hasAuthorship W1860174057A5055850706 @default.
- W1860174057 hasAuthorship W1860174057A5071041099 @default.
- W1860174057 hasBestOaLocation W18601740571 @default.
- W1860174057 hasConcept C104317684 @default.
- W1860174057 hasConcept C13373296 @default.
- W1860174057 hasConcept C150194340 @default.
- W1860174057 hasConcept C185592680 @default.
- W1860174057 hasConcept C190727270 @default.
- W1860174057 hasConcept C203014093 @default.
- W1860174057 hasConcept C2776914184 @default.
- W1860174057 hasConcept C2778329239 @default.
- W1860174057 hasConcept C2778690821 @default.
- W1860174057 hasConcept C2779138994 @default.
- W1860174057 hasConcept C2780931953 @default.
- W1860174057 hasConcept C55493867 @default.